Knee osteoarthritis
Stage I–II, where surgery has not been recommended
For early and mid-stage knee osteoarthritis, cartilage, meniscus and ligament damage, in Istanbul, Türkiye. A specialist physician first reviews your reports and tells you clearly whether the treatment is suitable for you.
Applying does not commit you to treatment. We reply within 2 working days.

It is considered for knee problems that do not yet require surgery. Your stage is determined by your X-ray / MRI images and a physician's examination.
Stage I–II, where surgery has not been recommended
Early and moderate cartilage wear
Stage I–II and early stage III tears
Stage I–II, together with rehabilitation
In advanced stages (stage IV), exosomes do not replace surgery; they can only be used to support the surgical process.
Share your X-ray, MRI or CT images via the form or WhatsApp.
A specialist physician reviews your documents. If you are suitable, a written quote is sent; if no benefit is expected, we tell you so clearly.
After the examination and your consent, the injection is given into the joint under sterile conditions with anaesthesia.
3 days of joint rest, physiotherapy and hydrotherapy if needed. Check-ups at weeks 4–6 and months 6–8.
Treatment takes place at İstanbul Medikal Termal on the Asian side of Istanbul. Exercising in warm thermal water reduces the load on the knee, so you start moving earlier and with less strain.
Supported by a team of physiotherapists, nurses and dietitians.
The answers are for general information. Your physician will give you answers specific to you.
In regenerative medicine, allogeneic exosomes derived from Wharton's jelly mesenchymal stem cells of umbilical cord tissue (MSC-WJ-Exosome) are used in orthopaedics, traumatology and physical therapy. In the knee they are mainly considered for osteoarthritis, cartilage damage, meniscus tears and ligament injuries.
Exosomes take part in communication between cells by carrying molecules such as proteins, lipids and RNA. In joint and soft-tissue diseases, their anti-inflammatory and immunomodulatory effects through growth factors, cytokines and chemokines are being researched. Through these effects, they are thought to help reduce inflammation and tissue breakdown and support repair.
No. Exosomes are messenger vesicles that all cells, including stem cells, use to communicate with each other. Exosome therapy and stem cell therapy are different; no living cells are injected in exosome therapy.
PRP is a platelet-rich product prepared from the person's own blood (autologous). Exosomes, by contrast, are an allogeneic product made from umbilical cord tissue using special methods in GMP / cGMP-certified laboratories licensed by the Ministry of Health of the Republic of Türkiye.
Hyaluronic acid injections reduce friction in the joint. Hyaluronic acid is metabolised by the body after a certain time, so its effect is temporary. Cortisone injections reduce inflammation and pain in the joint. Neither aims at tissue renewal. Exosomes, on the other hand, are being researched for their regenerative effects. Your physician will explain the option that suits you.
Yes. The molecules exosomes carry differ according to the cells they come from and the production method. Our physicians prefer allogeneic exosome products derived from Wharton's jelly mesenchymal stem cells of umbilical cord tissue (MSC-WJ-Exosome), one of the most frequently studied sources in regenerative medicine research. The product's source and test results are shown in the Product Analysis Certificate given to you.
It is mainly considered for stage I and II osteoarthritis. Results vary from person to person and no specific result can be guaranteed. The aim is more comfortable movement together with other treatments.
Yes. It can be applied in early and moderate stages that do not yet require surgery.
Laboratory and early clinical studies suggest that the regenerative effects of exosomes may support new cartilage formation. Because large, long-term studies in humans are still limited, this cannot be promised to every patient.
It can be considered for stage I and II tears and early stage III tears where no decision for surgery has been made, to support the healing process.
It can be considered for stage I and II ligament injuries, together with rehabilitation, to support the healing process.
We cannot promise this. When surgery is needed, exosomes do not replace it. For stage I–II soft-tissue damage and osteoarthritis, the physician may suggest a non-surgical plan together with physiotherapy; this does not apply to every patient. In advanced stages, a procedure before surgery can be used to support recovery after surgery.
For some stage I–II meniscus and cartilage damage, the physician may consider a non-surgical treatment plan suitable; this decision is based on examination and imaging. In advanced damage, exosomes do not replace surgery, but they can be applied before surgery to support the healing process.
There is no specific age limit. General health, the stage of the disease and the expected benefit of treatment are assessed together.
For non-permanent stage I and II cartilage degeneration, 1–2 sessions are usually planned. For permanent orthopaedic and physical damage, the physician creates a treatment plan specific to the patient's general condition and the case.
The plan is set according to your clinical condition. For stage I–II soft-tissue damage and osteoarthritis, 1–2 sessions 6–8 months apart are usually planned.
For stage I–II soft-tissue damage and osteoarthritis, a single session may be enough. A follow-up examination after 6–8 months is still required.
The response to treatment usually begins to be assessed 4–6 weeks after the procedure. Long-term human studies on how long the effect lasts are still limited, so we do not promise a specific duration. In our protocol the effect is checked at months 6–8, and whether a second session is needed is discussed at that time. Not everyone responds in the same way.
Usually only the needle is felt. For your comfort, anaesthesia chosen by the physician according to your diagnosis and the procedure method is applied, so pain during the procedure is kept to a minimum. For a few days after the procedure the knee may feel tender or full.
Yes, if your physician considers it suitable for you.
Short, controlled walking is usually possible after joint injections.
Yes. The joint should be rested for 3 days after the procedure.
Plan at least 4–5 days for the examination, the procedure and the 3-day rest period. If the physician recommends physiotherapy and hydrotherapy, the stay is extended accordingly. We recommend booking your flight after you have received the physician's pre-assessment and the written quote.
When you leave, you are given a treatment summary report and an exercise plan; you can share these with your family doctor or physiotherapist. You can reach our healthcare team on WhatsApp with your questions. If you have signs of infection such as fever, increasing pain, marked swelling, redness or warmth in the knee, see a physician or an emergency department in your country without delay.
It depends on the diagnosis and the degree of damage. In general:
Yes. You should continue physiotherapy and exercises suited to your condition. Exosome treatment does not replace them; its aim is to support your recovery.
Pain, swelling and bruising at the injection site and a reaction in the joint may occur. That is why it is important that the procedure is performed by a physician at a licensed healthcare facility.
Every joint injection carries a risk of infection, even if low. The products are manufactured with a high level of sterilisation in GMP / cGMP-certified laboratories licensed by the Ministry of Health of the Republic of Türkiye, and the procedure is performed under sterile conditions. Follow the hygiene rules recommended by your physician after the procedure. If you have fever, increasing pain, redness or warmth in the knee, contact us or a physician immediately.
Allergic reactions to MSC-WJ-Exosome products are considered rare; these products are also being researched for their immunomodulatory and anti-inflammatory effects. No injection is completely risk-free, so tell your physician about your allergies before treatment.
Taking blood thinners is not an automatic barrier to every joint injection. However, your bleeding risk must be assessed individually. Tell your physician which medicine you take and do not stop it without your physician's advice.
Controlled diabetes or other chronic diseases are not a barrier on their own. In patients whose blood sugar or disease is not under control, the procedure may be postponed. Please share your medical history and all the medicines you take in your application.
The physician makes the final decision. The procedure is usually not performed, or is postponed, in the following cases:
The product is manufactured in a GMP / cGMP-certified laboratory licensed by the Ministry of Health of the Republic of Türkiye and is prepared in the name of the healthcare facility, the treating physician and the patient. For each product, the laboratory issues the following documents:
These documents are handed to you or your relatives in person by the healthcare facility.
Depending on your complaint and diagnosis, the healthcare facility and the treating physician may ask for diagnosis and test results, radiological imaging (MRI, CT or X-ray) and, if you have had surgery before, the discharge report.
Send a few details and, if you have them, your imaging reports. Our healthcare team replies within 2 working days.